Literature DB >> 20339374

The role of sympathetic nervous activity in renal injury and end-stage renal disease.

Kazuko Masuo1, Gavin W Lambert, Murray D Esler, Hiromi Rakugi, Toshio Ogihara, Markus P Schlaich.   

Abstract

Sympathetic nervous system hyperactivity is observed in patients with renal injury, renovascular hypertension, chronic kidney disease (CKD) and end-stage renal disease (ESRD). Elevated sympathetic activity is of prognostic relevance in that plasma norepinephrine concentrations predict survival and the incidence of cardiovascular events in patients with ESRD, as well as future renal injury in normotensive healthy subjects with renal function in the normal range. Renal injury, CKD and ESRD are often associated with obesity, and its common sequelae hypertension and diabetes. In fact, hypertension and diabetes mellitus are the main causes of ESRD in western societies and together account for approximately more than 50% of ESRD incidence in the United States and Japan. Obesity also leads to increases in the incidence of cardiovascular diseases. Several clinical and epidemiological studies have clearly documented that heightened sympathetic nervous activity has an important role in the onset and maintenance of obesity and hypertension. Elevated sympathetic nervous activity may actually represent an important mechanism contributing to the onset and maintenance of renal injury at least in part through its concomitant adverse effects on obesity and hypertension. Understanding the contribution of sympathetic nervous hyperactivity to the onset and maintenance of renal injury might aid in the prevention and treatment of renal injury, CKD and ESRD. Very recently, renal sympathetic denervation was shown to be a potentially novel therapeutic strategy in resistant hypertension. In addition, renin-angiotensin system inhibitors are recommended as the initial therapy because of their renal protective effect, especially in hypertensive patients with type 2 diabetes or with proteinuria. The purpose of this review is to provide an overview of our current knowledge on the relationships between sympathetic nerve activity and renal function to further our understanding of the precise roles of sympathetic nerve activity in renal injury, particularly in the context of obesity and hypertension. These insights may be useful to improve prevention and treatment of renal injury in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339374     DOI: 10.1038/hr.2010.35

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  32 in total

1.  Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients.

Authors:  Yu-Ming Chang; Chih-Chung Shiao; Kuo-Chi Chang; I-Ling Chen; Chuan-Lan Yang; Show-Chin Leu; Hung-Li Su; Jsun-Liang Kao; Shih-Ching Tsai; Rong-Na Jhen
Journal:  Clin Exp Nephrol       Date:  2015-10-28       Impact factor: 2.801

Review 2.  Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy.

Authors:  Jane Yellowlees Douglas; Ashay D Bhatwadekar; Sergio Li Calzi; Lynn C Shaw; Debra Carnegie; Sergio Caballero; Quihong Li; Alan W Stitt; Mohan K Raizada; Maria B Grant
Journal:  Prog Retin Eye Res       Date:  2012-05-15       Impact factor: 21.198

Review 3.  Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.

Authors:  Valentina Carubelli; Marco Metra; Carlo Lombardi; Luca Bettari; Silvia Bugatti; Valentina Lazzarini; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 4.  Regulation of geminin by neuropeptide Y in vascular smooth muscle cell proliferation : A current review.

Authors:  S-Y Liang; Y-L Zhou; M-Q Shu; S Lin
Journal:  Herz       Date:  2018-08-27       Impact factor: 1.443

5.  PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.

Authors:  Francesco Fici; Elif Ari Bakir; Elif Ilkay Yüce; Serdal Kanuncu; Wim Makel; Bahar Arican Tarim; Nicolás Roberto Robles
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-01-09

Review 6.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

7.  Habitual sleep and kidney function in chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Authors:  Kristen L Knutson; James Lash; Ana C Ricardo; James Herdegen; J D Thornton; Mahboob Rahman; Nicolas Turek; Janet Cohan; Lawrence J Appel; Lydia A Bazzano; Manjula K Tamura; Susan P Steigerwalt; Matthew R Weir; Eve Van Cauter
Journal:  J Sleep Res       Date:  2017-06-23       Impact factor: 3.981

8.  Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease.

Authors:  Ye Zhao; Neal X Chen; Jonathan T Shirazi; Changyu Shen; Shien-Fong Lin; Michael C Fishbein; Sharon M Moe; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2015-12-29       Impact factor: 6.343

9.  Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats.

Authors:  Jan Mulder; Tomas Hökfelt; Mark M Knuepfer; Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-13       Impact factor: 3.619

Review 10.  Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Mahnoor Mir; Robert Chilton
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.